Rite Aid ups guidance after revenue beat

 

• Retail Comparable Store Prescriptions Increased 0.9 Percent – Comparable Store Non-COVID Acute Prescriptions Increased 11.9 Percent

• Revenues of $6.01 billion, Compared to Prior Year Revenues of $6.16 billion

• Net Loss per Share of $2.03, Compared to Prior Year Net Loss per Share of $0.24

• Adjusted Net Loss per Share of $0.60, Compared to Prior Year Adjusted Net Income per Share of $0.38, Driven by Non-Cash Impairment Charges and Cycling Prior Year COVID Vaccination Benefit

• Adjusted EBITDA of $100.1 million, Compared to the Prior Year Adjusted EBITDA of $138.9 million

• Increases Fiscal 2023 Revenue and Maintains Fiscal 2023 Adjusted EBITDA Guidance

https://finance.yahoo.com/news/rite-aid-corporation-reports-fiscal-110000772.html